COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review

Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: Data from the DA‐COVID‐19 registry

(2021) Andrea Chiricozzi et al.   ALLERGY

Young HIV‐positive male patient with severe atopic dermatitis on dupilumab and SARS‐CoV‐2 infection, a pioneer hypothesis

(2021) María F. Ordóñez‐Rubiano et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics

(2021) J.P. Thyssen et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Dupilumab and COVID ‐19: What should we expect?

(2020) Cataldo Patruno et al.   Dermatologic Therapy

Considerations for Safety in the Use of Systemic Medications for Psoriasis and Atopic Dermatitis during the COVID ‐19 pandemic

(2020) Jose W. Ricardo et al.   Dermatologic Therapy

COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab

(2020) Ulrike Förster-Ruhrmann et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Patient-Driven Discontinuation of Dupilumab During the COVID-19 Pandemic in Two Academic Hospital Clinics at the University of Toronto

(2020) Jorge R. Georgakopoulos et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Safety of dupilumab in atopic patients during COVID-19 outbreak

(2020) Maddalena Napolitano et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears

(2020) Matteo Megna et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy

(2020) Claudio Marasca et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

SARS‐CoV‐2 asymptomatic infection in a patient under treatment with dupilumab

(2020) Francesca Caroppo et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Safety of dupilumab in severe atopic dermatitis and infection of Covid‐19: two case reports

(2020) S. Ferrucci et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

No evidence of increased risk for COVID‐19 infection in patients treated with Dupilumab for atopic dermatitis in a high‐epidemic area ‐ Bergamo, Lombardy, Italy

(2020) A. Carugno et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Dupilumab, Severe Asthma Airway Responses, and SARS‐CoV2 Serology

(2020) Anurag Bhalla et al.   ALLERGY

Teledermatology and chronic skin diseases: Real life experience in a Southern Italian Dermatologic Centre

(2020) Alessia Villani et al.   Dermatologic Therapy

Management of adult patients with severe atopic dermatitis treated with dupilumab during COVID ‐19 pandemic: A single‐center real‐life experience

(2020) Mariateresa Rossi et al.   Dermatologic Therapy

Dupilumab in atopic dermatitis, a protocol for SARS‐COV 2 infected patients

(2020) Maria Fernanda Ordóñez‐Rubiano et al.   Dermatologic Therapy

Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic

(2020) Donovan G. Kearns et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Teledermatology for acne during COVID‐19: high patients’ satisfaction in spite of the emergency

(2020) A. Ruggiero et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Longitudinal analyses reveal immunological misfiring in severe COVID-19

(2020) Carolina Lucas et al.   NATURE

Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients

(2020) Valeria Cento et al.   JOURNAL OF INFECTION

Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy

(2020) Katrien Eger et al.   RESPIRATORY MEDICINE

Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia

(2020) Naoya Tanabe et al.   ALLERGOLOGY INTERNATIONAL

Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis

(2019) Lawrence F. Eichenfield et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis

(2019) Margitta Worm et al.   JAMA Dermatology

The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma

(2019) Giancarlo Marone et al.   Frontiers in Pharmacology

Dupilumab does not affect correlates of vaccine-induced immunity: a randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis

(2018) Andrew Blauvelt et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

(2017) Andrew Blauvelt et al.   LANCET

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

(2016) Eric L. Simpson et al.   NEW ENGLAND JOURNAL OF MEDICINE

T Cell Responses to Whole SARS Coronavirus in Humans

(2014) C. K.-f. Li et al.   JOURNAL OF IMMUNOLOGY